SAN FRANCISCO, March 11, 2019 /PRNewswire/ -- The global biopharmaceutical excipients market size is expected to reach USD 2.7 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.08% over the forecast period. Rapid expansion of the biopharmaceutical industry due to increasing manufacturing capacities is one of the key driving force of this market. Rise in the number of protein therapeutics coupled with the presence of a substantial number of excipients to protect these proteins from degradation is also driving the market growth.
Key suggestions from the report:
- Easy availability and wide usage of dextrose, sucrose, and starch in biopharmaceutical formulations has resulted in the largest revenue share of carbohydrates
- Polyols is expected to be the fastest-growing product segment in the global biopharmaceutical excipients market
- This can be attributed to increasing concerns regarding protein degradation, which can be reduced by using polyols
- North America led the global market in 2017 accounting for the largest revenue share as a result of the presence of key biopharmaceutical manufacturers in U.S.
- Emerging markets, such as India and China, are projected to be driven by the contract manufacturers operating in these regions
- Some major biopharmaceutical excipient suppliers are Merck KGaA; Roquette; Clariant; DFE Pharma; SPI Pharma, Inc.; and JRS Pharma LP
- Most of these companies are engaged in establishing partnerships with biopharmaceutical manufacturers to understand their needs and develop raw materials specific to the process and end-product
Read 200 page research report with TOC on "Biopharmaceutical Excipients Market Size, Share & Trends Analysis Report By Product (Solubilizers & Surfactants/Emulsifiers, Specialty Excipients, Polyols, Carbohydrates), By Region, And Segment Forecasts, 2019 - 2025" at: https://www.grandviewresearch.com/industry-analysis/biopharmaceutical-excipients-market
Investigational studies that are implemented for the impact analysis of excipient variability on in vitro dissolution testing are expected to reduce the attrition rate of final products and increase the reproducibility. These studies help scientists in gaining insights on the in vivo functioning and pharmacodynamic analysis of large molecules. The market exhibits continuous need of innovative excipient technologies to prolong the in vivo effectiveness of biologics and for improvement in the product delivery. Moreover, extensive R&D for the development of raw materials that help improve yields in mammalian cell-culture processes is expected to drive the market in future.
- Biopharmaceutical Excipients Product Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
- Solubilizers & Surfactants/Emulsifiers
- Triglycerides
- Esters
- Others
- Polyols
- Mannitol
- Sorbitol
- Others
- Carbohydrates
- Dextrose
- Sucrose
- Starch
- Others
- Specialty Biopharmaceutical Excipients/Others
- Biopharmaceutical Excipients Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- Japan
- China
- India
- Malaysia
- South Korea
- Philippines
- New Zealand
- Australia
- Singapore
- Indonesia
- Latin America
- Brazil
- Middle East & Africa
- South Africa
Find more research reports on Pharmaceutical Industry, by Grand View Research:
- Tissue Sealants Market - Tissue sealants market is expected to grow over the forecast period owing to the increasing surgical procedure
- Wound Care Sealants Market - The global wound care sealants market is expected to experience a lucrative growth on account of increasing number of surgeries all over the world
- Neurometabolic Disorders Market - The Global neurometabolic disorders market is expected to grow at lucrative rate during the forecast period owing to the increasing incidence of various neurometabolic disorders
Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter
https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg
